Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.”

Screenshot 2015-08-26 14.44.48


In the news story,  pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from a research study he had participated in that was published in a medical journal regarding the antipsychotice drug Risperdal and its use in children.


Drug company accused of altering study by top SickKids pediatrician, The Toronto Star, July 31, 2015